HK1011283A1 - Stable lyophilized thiotepa composition - Google Patents
Stable lyophilized thiotepa composition Download PDFInfo
- Publication number
- HK1011283A1 HK1011283A1 HK98112289A HK98112289A HK1011283A1 HK 1011283 A1 HK1011283 A1 HK 1011283A1 HK 98112289 A HK98112289 A HK 98112289A HK 98112289 A HK98112289 A HK 98112289A HK 1011283 A1 HK1011283 A1 HK 1011283A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- thiotepa
- composition
- pharmaceutically acceptable
- freeze
- solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15050193A | 1993-11-09 | 1993-11-09 | |
| US150501 | 1993-11-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HK1011283A1 true HK1011283A1 (en) | 1999-07-09 |
| HK1011283B HK1011283B (en) | 2000-04-28 |
Family
ID=
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Izutsu et al. | Physical stability and protein stability of freeze-dried cakes during storage at elevated temperatures | |
| JP3576180B2 (ja) | 改良イフォスファミド凍結乾燥組成物 | |
| EP1796647B1 (en) | Stable pegylated interferon formulation | |
| US7311908B2 (en) | Pharmaceutical compositions of fibrinolytic agent | |
| EP0656211B1 (en) | Stable lyophilized thiotepa composition | |
| US5036060A (en) | Cyclophosphamide | |
| KR102459213B1 (ko) | 카르글룸산을 함유하는 약제학적 비경구 제형 | |
| US5130305A (en) | Cyclophosphamide - sodium bicarbonate lyophilizates | |
| EP0134568B1 (en) | Stable antibacterial lyophilizates | |
| KR20070084150A (ko) | 세팔로스포린 유도체를 위한 안정화된 동결건조 제형물 | |
| HK1011283B (en) | Stable lyophilized thiotepa composition | |
| HK1250140A1 (zh) | 制备冷冻乾燥的含有丝裂霉素c的药物组合物的方法 | |
| EP0394045A2 (en) | Cyclophosphamide lyophilizates | |
| JPH02707A (ja) | 細胞増殖抑制性アントラサイクリン抗生物質の安定化された乾燥製剤 | |
| EP4364566A1 (en) | Anti-fungal composition | |
| HK1250140B (en) | Method for producing a freeze-dried pharmaceutical composition containing mitomycin c | |
| HK1208351A1 (en) | Method for producing a freeze-dried pharmaceutical composition containing mitomycin c | |
| HK1208351B (en) | Method for producing a freeze-dried pharmaceutical composition containing mitomycin c | |
| GB2167302A (en) | Stable lyophilized antibacterial preparations | |
| GB2217202A (en) | Trimelamol-containing pharmaceutical compositions | |
| US20070299139A1 (en) | Lyophilisate Comprising N-Diaminomethylene-2-Methyl-4,5-Di(Methylsulfonyl)Benzamide | |
| HK1103977B (en) | Stable pegylated interferon formulation | |
| GB2271281A (en) | Stabilised cyclophosphamide compositions | |
| HK1068500A (en) | Pharmaceutical compositions of fibrinolytic agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PF | Patent in force | ||
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20061109 |